Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusid GV, Schellong S, Mellado M, del Valle Morales M, Gavn-Sebastin O, Mazzolai L, Krumholz HM , Monreal M, Prandoni P, Brenner B, Farge-Bancel D, Barba R, Bertoletti L, Tzoran I, Reis A, Bosevski M, Bounameaux H, Mal R, Verhamme P, Caprini J, Adarraga M, Agudo de Blas P, Aibar J, Amado C, Arcelus J, Ballaz A, Barbagelata C, Barrn M, Barrn-Andrs B, Blanco-Molina , Beddar Chaib F, Botella E, Buo-Ramilo B, Castro J, Chasco L, Criado J, de Ancos C, de Miguel J, del Toro J, Demelo-Rodrguez P, Daz-Brasero A, Daz-Pedroche M, Daz-Peromingo J, Daz-Simn R, Domnguez I, Dubois-Silva , Escribano J, Espsito F, Farfn-Sedano A, Fernndez-Capitn C, Fernndez-Reyes J, Fidalgo , Font C, Francisco I, Gabara C, Galeano-Valle F, Garca M, Garca-Bragado F, Garca de Herreros M, Garca de la Garza R, Garca-Daz C, Gil-Daz A, Gimnez-Suau M, Gmez-Cuervo C, Grau E, Guirado L, Gutirrez J, Hernndez-Blasco L, Jara-Palomares L, Jaras M, Jimnez D, Jimnez R, Jimnez-Alfaro C, Jou I, Joya M, Lainez-Justo S, Lalueza A, Latorre-Dez A, Lobo J, Lpez-Jimnez L, Lpez-Miguel P, Lpez-Nez J, Lpez-Reyes R, Lpez-Sez J, Lorenzo A, Madridano O, Maestre A, Marchena P, Martn del Pozo M, Martn-Martos F, Martnez-Urbistondo D, Mella C, Mercado M, Muoz-Blanco A, Nieto J, Nez-Fernndez M, Olid-Velilla M, Otalora S, Otero R, Paredes-Ruiz D, Parra P, Parra V, Pedrajas J, Peris M, Porras J, Portillo J, Ruiz-Artacho P, Ruiz-Gimnez N, Ruiz-Ruiz J, Ruiz-Sada P, Salgueiro G, Snchez-Martnez R, Snchez-Muoz-Torrero J, Sancho T, Soler S, Surez-Rodrguez B, Suriach J, Tolosa C, Torres M, Torres-Snchez A, Uresandi F, Valero B, Valle R, Varona J, Vzquez-Friol C, Vela L, Vela J, Villalobos A, Villares P, Zamora C, Ay C, Nopp S, Pabinger I, Engelen M, Vanassche T, Yoo H, Hirmerova J, Accassat S, Ait Abdallah N, Bura-Riviere A, Catella J, Couturaud F, Crichi B, Debourdeau P, Espitia O, Falvo N, Grange C, Helfer H, Lacut K, Le Mao R, Mah I, Morange P, Moustafa F, Poenou G, Sarlon-Bartoli G, Suchon P, Quere I, Nikandish R, Braester A, Kenet G, Basaglia M, Bilora F, Bortoluzzi C, Brandolin B, Ciammaichella M, Corgna C, de Angelis A, Imbalzano E, Mastroiacovo D, Merla S, Pesavento R, Pomero F, Siniscalchi C, Tufano A, Vison A, Vo Hong N, Zalunardo B, Kigitovica D, Rusa E, Skride A, Fonseca S, Martins-Duarte F, Meireles J
NAFLD: Nonalcoholic fatty liver disease
Several GLP-1 agonists are being investigated in clinical trials as potential ways to slow or stop Parkinsons progression
V.MartindaleR
Outcomes were not projected beyond a 1-year time horizon, and therefore cost and clinical outcomes were not discounted
